ALPHA TRIBE

Mangalam Drugs And Organics LimitedBoard Meeting, 15-01-2026: Outcome of Board Meeting

15-01-2026 | 05:37 pm

Mangalam Drugs' board approved the consolidated financial results for the quarter and nine months ended Dec 31, 2025, showing a net loss of ₹9.84 Cr on sales of ₹58.38 Cr. The CFO and Company Secretary also resigned, effective Jan 31 and Mar 29, 2026, respectively.

No comments yet. Be the first to comment!

All announcements from Mangalam Drugs And Organics Limited